The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?

Published:2023-03-31 Issue:10 Volume:38 Page:2099-2104
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Chowdhury Raad B¹,Kastritis Efstathios²,Rajkumar S Vincent³,Leung Nelson¹³

Affiliation:

1. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic , Rochester, MN , USA

2. Department of Clinical Therapeutics, National and Kapodistrian University of Athens , Athens , Greece

3. Division of Hematology, Department of Medicine, Mayo Clinic , Rochester, MN , USA

Funder

Amgen

Jansee

GSK

Pfizer

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad061/51208406/gfad061.pdf

Reference10 articles.

1. Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry;Courant;Nephrol Dial Transplant,2021

2. Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical trial;Bridoux;JAMA,2017

3. Acute kidney injury in bortezomib-treated patients with multiple myeloma;Song;Nephrol Dial Transplant,2023

4. World incidence of AKI: a meta-analysis;Susantitaphong;Clin J Am Soc Nephrol,2013

5. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma;San Miguel;N Engl J Med,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP